Texas Biomed researchers complete critical preclinical study to advance potential tuberculosis therapy toward human clinical trials
Throughout his 23-year career, Stanton Gray, D.V.M., Ph.D., DACLAM, has sought to improve animal and human health as a veterinarian, colony manager and researcher
SAN ANTONIO (May 9, 2024) β Wearing many hats comes naturally to Kathryn Shelton, D.V.M., Ph.D., DACLAM. This is a strength sheβll tap into as she joins Texas Biomedical Research Institute (Texas Biomed) and Southwest National Primate Research Center (SNPRC) with not one, not two, but three official roles: Associate Director for Veterinary Resources, Institute…
Preclinical findings provide strong evidence for moving vaccine candidate forward in first-of-its-kind study A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according…
In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus…
Nine Texas Biomed scientists have received more than $628,000 in philanthropic funding to study a range of infectious diseases β including Ebola virus, Chikungunya virus and tuberculosis β and develop…